Optimal glycemic control is fundamental to the management of diabetes.



A1C% measurement approximately every 3 months determines whether patients’ glycemic targets have been reached and maintained. The frequency of A1C testing should depend on the clinical situation, the treatment regimen, and the clinician’s judgment.



Glycemic targets should be individualized. In most people with type 1 or type 2 diabetes, an A1C ≤7.0% should be targeted to reduce the risk of microvascular and, if implemented early in the course of disease, CV complications.



Sources: latest American & Canadian Diabetes Association guidelines



#management #endocrinology #diabetes #decisionaid #treatment #table